1. Home
  2. RCMT vs ELDN Comparison

RCMT vs ELDN Comparison

Compare RCMT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$18.51

Market Cap

150.7M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$2.00

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
ELDN
Founded
1971
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.7M
166.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCMT
ELDN
Price
$18.51
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$30.00
$8.50
AVG Volume (30 Days)
47.0K
548.9K
Earning Date
03-11-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.71
N/A
Revenue
$309,840,000.00
N/A
Revenue This Year
$16.29
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
$10.72
N/A
Revenue Growth
13.70
N/A
52 Week Low
$13.18
$1.35
52 Week High
$28.27
$4.65

Technical Indicators

Market Signals
Indicator
RCMT
ELDN
Relative Strength Index (RSI) 27.81 49.31
Support Level $17.26 $1.96
Resistance Level $21.41 $2.22
Average True Range (ATR) 0.74 0.13
MACD -0.32 -0.03
Stochastic Oscillator 3.86 20.08

Price Performance

Historical Comparison
RCMT
ELDN

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: